Skip to content
2000
Volume 4, Issue 1
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The favourable nuclear properties of copper-67 and rhenium-188 for therapeutic application are described, together with methods for the chemical synthesis of a number of derivatives. Survival from invasive bladder cancer has changed little over the past 20 years. The intravesicular administration of Cu-67 or Re-188 radiopharmaceuticals in the treatment of bladder cancer offers some promise for improvement in this situation.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557043487510
2004-01-01
2025-09-21
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557043487510
Loading

  • Article Type:
    Review Article
Keyword(s): Cancer, Radioimmunotherapy; Copper-67, Bladder; Rhenium-188
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test